PL396494A1 - Sposób oznaczania grupy krwi i uklad do oznaczania grupy krwi - Google Patents

Sposób oznaczania grupy krwi i uklad do oznaczania grupy krwi

Info

Publication number
PL396494A1
PL396494A1 PL396494A PL39649411A PL396494A1 PL 396494 A1 PL396494 A1 PL 396494A1 PL 396494 A PL396494 A PL 396494A PL 39649411 A PL39649411 A PL 39649411A PL 396494 A1 PL396494 A1 PL 396494A1
Authority
PL
Poland
Prior art keywords
determining blood
blood groups
detector
microfluidic channel
connector
Prior art date
Application number
PL396494A
Other languages
English (en)
Other versions
PL219803B1 (pl
Inventor
Sylwia Makulska
Sławomir Jakieła
Piotr Garstecki
Original Assignee
Instytut Chemii Fizycznej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Fizycznej Polskiej Akademii Nauk filed Critical Instytut Chemii Fizycznej Polskiej Akademii Nauk
Priority to PL396494A priority Critical patent/PL219803B1/pl
Priority to NL2009403A priority patent/NL2009403C2/en
Publication of PL396494A1 publication Critical patent/PL396494A1/pl
Publication of PL219803B1 publication Critical patent/PL219803B1/pl

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40Static mixers
    • B01F25/42Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions
    • B01F25/43Mixing tubes, e.g. wherein the material is moved in a radial or partly reversed direction
    • B01F25/433Mixing tubes wherein the shape of the tube influences the mixing, e.g. mixing tubes with varying cross-section or provided with inwardly extending profiles
    • B01F25/4331Mixers with bended, curved, coiled, wounded mixing tubes or comprising elements for bending the flow
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • B01F33/302Micromixers the materials to be mixed flowing in the form of droplets
    • B01F33/3021Micromixers the materials to be mixed flowing in the form of droplets the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0867Multiple inlets and one sample wells, e.g. mixing, dilution
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0883Serpentine channels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0415Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Clinical Laboratory Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Przedmiotem wynalazku jest sposób oznaczania grupy krwi, obejmujący otrzymanie próbki (11) poprzez zmieszanie materiału badanego (8) z materiałem wzorcowym (9) oraz detekcję aglutynacji w tak otrzymanej próbce (11), charakteryzujący się tym, że wspomnianego zmieszania materiału badanego (8) z materiałem wzorcowym (9) dokonuje się w kanale (3) układu mikroprzepływowego. Wynalazek obejmuje także układ do oznaczania grupy krwi, obejmujący pierwszy kanał mikroprzepływowy (1) i drugi kanał mikroprzepływowy (2), łączące się w złączu (3) oraz trzeci kanał mikroprzepływowy (5), prowadzący od tego złącza (3) do pierwszego detektora (6), charakteryzujący się tym, że wspomnianym pierwszym detektorem (6) jest detektor czuły na zmianę natężenia światła.
PL396494A 2011-09-30 2011-09-30 Sposób oznaczania grupy krwi i układ do oznaczania grupy krwi PL219803B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL396494A PL219803B1 (pl) 2011-09-30 2011-09-30 Sposób oznaczania grupy krwi i układ do oznaczania grupy krwi
NL2009403A NL2009403C2 (en) 2011-09-30 2012-09-03 Method for determination of blood group and system for the same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL396494A PL219803B1 (pl) 2011-09-30 2011-09-30 Sposób oznaczania grupy krwi i układ do oznaczania grupy krwi

Publications (2)

Publication Number Publication Date
PL396494A1 true PL396494A1 (pl) 2013-04-02
PL219803B1 PL219803B1 (pl) 2015-07-31

Family

ID=48040876

Family Applications (1)

Application Number Title Priority Date Filing Date
PL396494A PL219803B1 (pl) 2011-09-30 2011-09-30 Sposób oznaczania grupy krwi i układ do oznaczania grupy krwi

Country Status (2)

Country Link
NL (1) NL2009403C2 (pl)
PL (1) PL219803B1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025781A1 (en) 2014-11-28 2016-06-01 Geomobile Sp. z o.o. A method for determinig agglutination

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113514646B (zh) * 2021-08-26 2023-11-24 深圳市亚辉龙生物科技股份有限公司 检测蛋白抗原的微流控芯片、方法、试剂盒和系统

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3025781A1 (en) 2014-11-28 2016-06-01 Geomobile Sp. z o.o. A method for determinig agglutination

Also Published As

Publication number Publication date
NL2009403A (en) 2013-04-03
PL219803B1 (pl) 2015-07-31
NL2009403C2 (en) 2013-08-14

Similar Documents

Publication Publication Date Title
MX345757B (es) Análisis de imagen y medición de muestras biológicas.
MX389083B (es) Anticuerpos anti-pd-l1 radiomarcados para imagenes de inmuno-pet.
NZ629703A (en) Methods and compositions for detecting multiple analytes with a single signal
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
EP3899022A4 (en) PORTABLE IMPEDANCE-BASED DIAGNOSTIC TEST SYSTEM FOR DETECTING ANALYTES
BR112015019614A8 (pt) análise de imagens e medições de amostras biológicas
SE0800724L (sv) Blodviskositetsanalys
MX377956B (es) Sistemas y métodos para maximización de uso de muestras.
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
BR112017009151A2 (pt) ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos
NZ596659A (en) Bulbless spectrometer
BR112015009932A8 (pt) métodos
GB2528657A8 (en) Sample analysing device
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
BR112017023726A2 (pt) detecção de fatores de virulência microbiana na cavidade oral
MX2016005834A (es) Ensayos para igfbp7 con mejor rendimiento en muestras biológicas.
BR112016022829A8 (pt) Dispositivo de teste para determinar a presença de um primeiro ligante em uma amostra líquida e método para testar uma amostra quanto à presença de um primeiro ligante
ATE541216T1 (de) Fluoreszenztestverfahren
BR112016017901A2 (pt) ensaio inovador para detectar periostina humana
EP3714276C0 (en) TEST SENSORS, SYSTEMS AND ANALYTICAL TECHNIQUES FOR MEASURING GLYCATED HEMOGLOBIN IN UNDILUTED BLOOD SAMPLES
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX2016011453A (es) Sistemas y metodos de codificacion para la calibracion de biosensores.
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome